Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

DoMore Diagnostics, Proscia Ink Collaboration on Colorectal Cancer Histopathology Testing

Proscia
By Author Proscia | August 30, 2023

Digital pathology firms DoMore Diagnostics and Proscia said that they are collaborating to help pathologists predict outcomes for colorectal cancer patients.

Read Full Article

Our website uses cookies. By using this site, you agree to its use of cookies.

Agree

Privacy Policy